Wh. Zhu et Tt. Loh, DIFFERENTIAL-EFFECTS OF PHORBOL ESTER ON APOPTOSIS IN HL-60 PROMYELOCYTIC LEUKEMIA-CELLS, Biochemical pharmacology, 51(9), 1996, pp. 1229-1236
The role of the protein kinase C (PKC) activator phorbol 12-myristate
13-acetate (PMA) in apoptosis of HL-60 cells was investigated. PMA inh
ibited DNA fragmentation induced by thapsigargin (TG) and 4-bromo-calc
ium ionophore (Br-A23187). The inhibitory effect of PMA was concentrat
ion-related and was abolished by a specific PKC inhibitor, bisindolylm
aleimide (GF109203X). In addition, TG-induced apoptosis was decreased
in cells in which PKC activity was down-regulated by long-term pretrea
tment with PMA. These results indicate that PKC activation by PMA inhi
bits HL-60 cell apoptosis induced by TG and Br-A23187, and that this i
nhibition is not influenced by the down-regulation of PKC. However, PM
A did not inhibit DNA fragmentation induced by 1-beta-D-arabinofuranos
ylcytosine (Ara-C) and cycbheximide. PMA suppressed TG- or Br-A23187-i
nduced DNA fragmentation probably by interfering in the modulation of
calcium homeostasis by TG and Br-A23187. Our results indicate that PKC
participates in the regulation of apoptosis only by some pathways. Do
wn-regulation of PKC is not responsible for the diverse effects of PKC
activators on apoptosis. The effect of a PKC modulator on apoptosis i
s dependent upon interaction with individual apoptotic stimulus.